NBIO (Nascent Biotech) OCF Margin %: 0.00% (As of Jun. 2024)


What is Nascent Biotech OCF Margin %?

Nascent Biotech NBIO +66.67% OCF Margin % is 0.00% as of Jun. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nascent Biotech's Cash Flow from Operations for the three months ended in Jun. 2024 was $-0.33 Mil. Nascent Biotech's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Nascent Biotech's OCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Nascent Biotech's current OCF Yield % is -1,568.60%.

The historical rank and industry rank for Nascent Biotech's OCF Margin % or its related term are showing as below:


NBIO's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Nascent Biotech OCF Margin % Related Terms

Nascent Biotech OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nascent Biotech's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Biotech OCF Margin % Chart

Nascent Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
OCF Margin %
Get a 7-Day Free Trial 0.00 -131.60 41.30 0.00 0.00

Nascent Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nascent Biotech OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nascent Biotech's OCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-1.186/0
= %

Nascent Biotech's OCF Margin for the quarter that ended in Jun. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.325/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Nascent Biotech (NBIO) has a OCF Margin % of 0.00% as of Jun. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nascent Biotech and its competitors.
Is Nascent Biotech's OCF Margin % too high?
Nascent Biotech's current OCF Margin % is 0.00%.
How does Nascent Biotech's OCF Margin % compare to BTAX and PXMD?
Nascent Biotech's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nascent Biotech and its competitors. Nascent Biotech's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nascent Biotech stock overvalued right now?
Nascent Biotech (NBIO) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nascent Biotech (NBIO), the current OCF Margin % is 0.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nascent Biotech Business Description

Address 631 US Hwy 1, Suite 407, N Palm Beach, FL, USA, 33408
Nascent Biotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is focused on the development and delivery of human antibodies and cytokine responses to the treatment of cancer. The company's products include Pritumumab, CLNH5, and MultiPharm. The company is engaged in the development of Pritumumab which would be used for the treatment of brain cancer and pancreatic cancer. The company is also exploring the use of Pritumumab against other viruses.